Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy

Bibliographic Details
Main Authors:	Chun-Yu Chen, Mohammed G Ghonime, Uksha Saini, Michael C Kelly, Justin C Roth, Pin-Yi Wang, Katherine Miller, Ilse Hernandez-Aguirre, Yeaseul Kim, Xiaokui Mo, Joseph R Stanek, Tim Cripe, Elaine Mardis, Kevin A Cassady
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-10-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/10/e002939.full

Similar Items

Toward comprehensive imaging of oncolytic viroimmunotherapy
by: Shyambabu Chaurasiya, et al.
Published: (2021-12-01)

The role of cancer metabolism in defining the success of oncolytic viroimmunotherapy
by: Dyer, A, et al.
Published: (2020)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity
by: Jun Xie, et al.
Published: (2023-06-01)

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
by: Yin L, et al.
Published: (2017-02-01)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates
by: Kevin A. Cassady, et al.
Published: (2017-06-01)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
by: Bangxing Hong, et al.
Published: (2022-01-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
by: Wei Zhang, et al.
Published: (2013-06-01)

The Antiviral Apparatus: STING and Oncolytic Virus Restriction
by: Joel Lee, et al.
Published: (2019-06-01)

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children
by: Timothy P Cripe, et al.
Published: (2015-01-01)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-11-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.
by: Lauren A Gillory, et al.
Published: (2013-01-01)

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
by: Hayle Scanlan, et al.
Published: (2022-07-01)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
by: Gregory K Friedman, et al.
Published: (2015-01-01)

Systemic cellular viroimmunotherapy for canine high-grade gliomas
by: Ramon Alemany, et al.
Published: (2022-12-01)

Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
by: Mohamed Abdelmoneim, et al.
Published: (2022-12-01)

Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts.
by: Guobin Zhang, et al.
Published: (2014-01-01)

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-12-01)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
by: Yanghee Woo, et al.
Published: (2020-03-01)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
by: Julia V. Cockle, et al.
Published: (2017-06-01)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
by: Jan B. Boscheinen, et al.
Published: (2019-01-01)

Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution
by: Jack Hedberg, et al.
Published: (2023-09-01)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
by: Kimia Kardani, et al.
Published: (2023-05-01)

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
by: Yoichiro Kawamura, et al.
Published: (2022-11-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
by: Michael L Megison, et al.
Published: (2014-01-01)

Oncolytic Herpes Simplex Virus-based Strategies: Toward a Breakthrough in Glioblastoma Therapy
by: Jianfang eNing, et al.
Published: (2014-06-01)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
by: Alicia M. Waters, et al.
Published: (2016-10-01)

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
by: Shusuke Okunaga, et al.
Published: (2015-10-01)

Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
by: Nicholas L. Denton, et al.
Published: (2018-12-01)

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival
by: Howard L Kaufman, et al.
Published: (2024-04-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
by: S. M. Bakhtiar Ul Islam, et al.
Published: (2020-01-01)